A proximal activator of transcription in epithelial-mesenchymal transition

被引:140
|
作者
Venkov, Christo D.
Link, Andrew J.
Jennings, Jennifer L.
Plieth, David
Inoue, Tsutomu
Nagai, Kojiro
Xu, Carol
Dimitrova, Yoana N.
Rauscher, Frank J., III
Neilson, Eric G.
机构
[1] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[4] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
[5] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2007年 / 117卷 / 02期
关键词
D O I
10.1172/JCI29544
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Epithelial-mesenchymal transition (EMT) is an important mechanism for phenotypic conversion in normal development and disease states such as tissue fibrosis and metastasis. While this conversion of epithelia is under tight transcriptional control, few of the key transcriptional proteins are known. Fibroblasts produced by EMT express a gene encoding fibroblast-specific protein 1 (FSP1), which is regulated by a proximal cis-acting promoter element called fibroblast transcription site-1 (FTS-1). In mass spectrometry, chromatin immunoprecipitation, and siRNA studies, we used FTS-1 as a unique probe for mediators of EMT and identified a complex of 2 proteins, CArG box-binding factor-A (CBF-A) and KRAB-associated protein 1 (KAP-1), that bind this site. Epithelial cells engineered to conditionally express recombinant CBF-A (rCBF-A) activate the transcription of FSP1 and undergo EMT. The FTS-1 response element also exists in the promoters modulating a broader EMT transcriptome, including Twist, and Snail, as well as E-cadberin, beta-catenin, ZO1, vimentin, alpha 1 (I) collagen, and alpha-smooth muscle actin, and the induction of rCBF-A appropriately alters their expression as well. We believe formation of the CBF-A/KAP-1/FTS-1 complex is sufficient for the induction of FSP1 and a novel proximal activator of EMT.
引用
收藏
页码:482 / 491
页数:10
相关论文
共 50 条
  • [1] Transcription activation in epithelial-mesenchymal transition
    Oliver, Juan
    KIDNEY INTERNATIONAL, 2007, 71 (10) : 965 - 966
  • [2] Epithelial-mesenchymal transition and its transcription factors
    Debnath, Pallabi
    Huirem, Rohit Singh
    Dutta, Paloma
    Palchaudhuri, Santanu
    BIOSCIENCE REPORTS, 2022, 42 (01)
  • [3] Epithelial-mesenchymal transition
    Kubik, Joanna
    Pawlak, Kamil
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2023, 36 (01) : 18 - 20
  • [4] Epithelial-Mesenchymal Transition
    Zavadil, Jiri
    Haley, John
    Kalluri, Raghu
    Muthuswamy, Senthil K.
    Thompson, Erik
    CANCER RESEARCH, 2008, 68 (23) : 9574 - 9577
  • [5] Epithelial-mesenchymal transition
    Radisky, DC
    JOURNAL OF CELL SCIENCE, 2005, 118 (19) : 4325 - 4326
  • [6] Regulation of Epithelial-Mesenchymal Transition through SUMOylation of Transcription Factors
    Bogachek, Maria V.
    De Andrade, James P.
    Weigel, Ronald J.
    CANCER RESEARCH, 2015, 75 (01) : 11 - 15
  • [7] The Emerging Roles of RUNX Transcription Factors in Epithelial-Mesenchymal Transition
    Voon, Dominic Chih-Cheng
    Thiery, Jean Paul
    RUNX PROTEINS IN DEVELOPMENT AND CANCER, 2017, 962 : 471 - 489
  • [8] Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells
    McMorrow, T
    Gaffney, MM
    Slattery, C
    Campbell, E
    Ryan, MP
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (10) : 2215 - 2225
  • [9] Transcriptional controls for epithelial-mesenchymal and mesenchymal epithelial transition
    Hay, ED
    FASEB JOURNAL, 2004, 18 (05): : A762 - A762
  • [10] Epithelial-mesenchymal transition in cancer
    Moustakas, Aristidis
    Garcia de Herreros, Antonio
    MOLECULAR ONCOLOGY, 2017, 11 (07): : 715 - 717